307 related articles for article (PubMed ID: 24519777)
1. [Is vaccination against varicella efficacious and how long does the protection last?].
Ołdak E
Med Wieku Rozwoj; 2013; 17(4):341-6. PubMed ID: 24519777
[TBL] [Abstract][Full Text] [Related]
2. The effect of vaccination on the epidemiology of varicella zoster virus.
Edmunds WJ; Brisson M
J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
[TBL] [Abstract][Full Text] [Related]
3. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
[TBL] [Abstract][Full Text] [Related]
4. [Vaccines against varicella-zoster virus (VZV)].
Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
[TBL] [Abstract][Full Text] [Related]
5. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
[TBL] [Abstract][Full Text] [Related]
6. Effects of varicella vaccination on herpes zoster incidence.
Wagenpfeil S; Neiss A; Wutzler P
Clin Microbiol Infect; 2004 Nov; 10(11):954-60. PubMed ID: 15521996
[TBL] [Abstract][Full Text] [Related]
7. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
[TBL] [Abstract][Full Text] [Related]
8. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT
Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890
[TBL] [Abstract][Full Text] [Related]
9. Varicella immunity in vaccinated healthcare workers.
Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
[TBL] [Abstract][Full Text] [Related]
10. Varicella zoster virus: vaccination and implications in children with renal failure.
Fadrowski JJ; Furth SL
Expert Rev Vaccines; 2004 Jun; 3(3):291-8. PubMed ID: 15176945
[TBL] [Abstract][Full Text] [Related]
11. The current status of live attenuated varicella vaccine.
Gershon AA
Arch Virol Suppl; 2001; (17):1-6. PubMed ID: 11339539
[TBL] [Abstract][Full Text] [Related]
12. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
[TBL] [Abstract][Full Text] [Related]
13. Live attenuated varicella vaccine use in immunocompromised children and adults.
Gershon AA; Steinberg SP; Gelb L
Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
[TBL] [Abstract][Full Text] [Related]
14. Varicella in Europe-A review of the epidemiology and experience with vaccination.
Helmuth IG; Poulsen A; Suppli CH; Mølbak K
Vaccine; 2015 May; 33(21):2406-13. PubMed ID: 25839105
[TBL] [Abstract][Full Text] [Related]
15. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
Goldman GS
Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
[TBL] [Abstract][Full Text] [Related]
16. Experience with the live Oka-strain varicella vaccine in children with solid tumours.
Heath RB; Malpas JS
Postgrad Med J; 1985; 61 Suppl 4(721):107-11. PubMed ID: 3014467
[TBL] [Abstract][Full Text] [Related]
17. Worldwide experience with the Oka-strain live varicella vaccine.
Andre FE
Postgrad Med J; 1985; 61 Suppl 4():113-20. PubMed ID: 3014468
[TBL] [Abstract][Full Text] [Related]
18. Varicella vaccination: a laboured take-off.
Carrillo-Santisteve P; Lopalco PL
Clin Microbiol Infect; 2014 May; 20 Suppl 5():86-91. PubMed ID: 24494784
[TBL] [Abstract][Full Text] [Related]
19. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
20. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
Breuer J; Schmid DS; Gershon AA
J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
